Form 8-K Horizon Pharma plc For: Aug 01

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Form 8-K Horizon Pharma plc For: Aug 01

BMO Capital Positive on Horizon Pharma (HZNP) Amid CVS/Caremark News; Affirms at 'Outperform'

August 2, 2016 12:38 PM EDT

BMO Capital affirms Horizon Pharma (Nasdaq: HZNP) at Outperform with a price target of $29 after the company announced that two of its primary care products Duexis and Vimovo were removed from the 2017 CVS/Caremark exclusion list.

Analyst Gary Nachman commented today, We view this announcement as an important win for HZNP. It demonstrates that it is improving its execution on the managed care front as... More

Horizon Pharma (HZNP) Says DUEXIS and VIMOVO Will be Covered by CVS/Caremark

August 2, 2016 7:13 AM EDT

Horizon Pharma (NASDAQ: HZNP) disclosed the following on Tuesday morning:

Item 7.01 Regulation FD Disclosure.

Horizon Pharma has secured covered status for DUEXIS and VIMOVO with CVS/Caremark. The Company has been informed that beginning January 1, 2017, DUEXIS and VIMOVO will be removed from the CVS/Caremark exclusion list.

... More